Radiological tumor size decrease at week 6 is a potent predictor of outcome in chemorefractory metastatic colorectal cancer treated with cetuximab (BOND trial)

Hubert H. Piessevaux, Marc E Buyse, Wendy De Roock et al. · Annals of Oncology · 2009

Cited by 82 works. doi:10.1093/annonc/mdp011

Authors

References